Volume 54, Issue 23 pp. 6684-6686

Highlight

Multiple Attack on Bacteria by the New Antibiotic Teixobactin^†

Dr. Franz von Nussbaum,

Corresponding Author

Dr. Franz von Nussbaum

[email protected]

Global Drug Discovery, Medicinal Chemistry Berlin, Bayer HealthCare (Germany)

Franz von Nussbaum, Global Drug Discovery, Medicinal Chemistry Berlin, Bayer HealthCare (Germany)

Roderich D. Süssmuth, Institut für Chemie, Technische Universität Berlin, 10623 Berlin (Germany)

Search for more papers by this author

Prof. Dr. Roderich D. Süssmuth,

Corresponding Author

Prof. Dr. Roderich D. Süssmuth

[email protected]

Institut für Chemie, Technische Universität Berlin, 10623 Berlin (Germany)

Franz von Nussbaum, Global Drug Discovery, Medicinal Chemistry Berlin, Bayer HealthCare (Germany)

Roderich D. Süssmuth, Institut für Chemie, Technische Universität Berlin, 10623 Berlin (Germany)

Search for more papers by this author

Dr. Franz von Nussbaum,

Corresponding Author

Dr. Franz von Nussbaum

[email protected]

Global Drug Discovery, Medicinal Chemistry Berlin, Bayer HealthCare (Germany)

Franz von Nussbaum, Global Drug Discovery, Medicinal Chemistry Berlin, Bayer HealthCare (Germany)

Roderich D. Süssmuth, Institut für Chemie, Technische Universität Berlin, 10623 Berlin (Germany)

Search for more papers by this author

Prof. Dr. Roderich D. Süssmuth,

Corresponding Author

Prof. Dr. Roderich D. Süssmuth

[email protected]

Institut für Chemie, Technische Universität Berlin, 10623 Berlin (Germany)

Franz von Nussbaum, Global Drug Discovery, Medicinal Chemistry Berlin, Bayer HealthCare (Germany)

Roderich D. Süssmuth, Institut für Chemie, Technische Universität Berlin, 10623 Berlin (Germany)

Search for more papers by this author

First published: 12 May 2015

https://doi.org/10.1002/anie.201501440

Citations: 43

^†

We thank Dr. John Weston (Frankfurt), Dr. Todor Baramov (TU Berlin), and Dr. Guido Schiffer (Bayer HealthCare) for stimulating discussions. The work was supported by the cluster of excellence “UniCat” (“unifying concepts in catalysis”), which is funded by the Deutsche Forschungsgemeinschaft (DFG).

Share a link

Email
Wechat
Bluesky

Graphical Abstract

News from the antibiotics pipeline: The discovery of a depsipeptide-type lipid II binder, isolated from a previously unknown bacterium, raises hopes in the battle against multiresistant staphylococci.

References

1L. L. Ling, T. Schneider, A. J. Peoples, A. L. Spoering, I. Engels, B. P. Conlon, A. Mueller, T. F. Schäberle, D. E. Hughes, S. Epstein, M. Jones, L. Lazarides, V. A. Steadman, D. R. Cohen, C. R. Felix, K. A. Fetterman, W. P. Millett, A. G. Nitti, A. M. Zullo, C. Chen, K. Lewis, Nature 2015, 517, 455–459.
10.1038/nature14098
CAS PubMed Web of Science® Google Scholar
2
2aP. M. Wright, I. B. Seiple, A. G. Myers, Angew. Chem. Int. Ed. 2014, 53, 8840–8869;
10.1002/anie.201310843
CAS PubMed Web of Science® Google Scholar
Angew. Chem. 2014, 126, 8984–9014;
10.1002/ange.201310843
Web of Science® Google Scholar
2bF. von Nussbaum, M. Brands, B. Hinzen, S. Weigand, D. Häbich, Angew. Chem. Int. Ed. 2006, 45, 5072–5129;
10.1002/anie.200600350
CAS PubMed Web of Science® Google Scholar
Angew. Chem. 2006, 118, 5194–5254.
10.1002/ange.200600350
Web of Science® Google Scholar
3J. Davies, D. Davies, Microbiol. Mol. Biol. Rev. 2010, 74, 417–433.
10.1128/MMBR.00016-10
CAS PubMed Web of Science® Google Scholar
4M. P. Singh, P. J. Petersen, W. J. Weiss, J. E. Janso, S. W. Luckman, E. B. Lenoy, P. A. Bradford, R. T. Testa, M. Greenstein, Antimicrob. Agents Chemother. 2003, 47, 62–69.
10.1128/AAC.47.1.62-69.2003
CAS PubMed Web of Science® Google Scholar
5E. Breukink, B. de Kruijff, Nat. Rev. Drug Discovery 2006, 5, 321–332.
10.1038/nrd2004
CAS PubMed Web of Science® Google Scholar
6A. Chugunov, D. Pyrkova, D. Nolde, A. Polyansky, V. Pentkovsky, R. Efremov, Sci. Rep. 2013, 3, 1678, DOI: 10.1038/srep01678.
10.1038/srep01678
PubMed Web of Science® Google Scholar
7I. Wiedemann, R. Benz, H.-G. Sahl, J. Bacteriol. 2004, 186, 3259–3261.
10.1128/JB.186.10.3259-3261.2004
CAS PubMed Web of Science® Google Scholar
8F. von Nussbaum, S. Anlauf, J. Benet-Buchholz, D. Häbich, J. Köbberling, L. Musza, J. Telser, H. Rübsamen-Waigmann, N. A. Brunner, Angew. Chem. Int. Ed. 2007, 46, 2039–2042;
10.1002/anie.200604232
CAS PubMed Web of Science® Google Scholar
Angew. Chem. 2007, 119, 2085–2088.
10.1002/ange.200604232
Web of Science® Google Scholar
9In the case of teixobactin, a 28-membered katanosin-like ring could also formally be constructed by lactonization of the C-terminal Ile¹¹ with Ser² instead of D-Thr⁸.
Google Scholar
10Based on the structural resemblance to teixobactin, hypeptin might also target lipid II. For the structure of hypeptin, see: J. Shoij, H. Hinoo, T. Hattori, K. Hirooka, Y. Kimura, T. J. Yoshida, J. Antibiot. 1989, 42, 1460–1464.
10.7164/antibiotics.42.1460
PubMed Web of Science® Google Scholar

Citing Literature

Volume54, Issue23

June 1, 2015

Pages 6684-6686

Multiple Attack on Bacteria by the New Antibiotic Teixobactin^†

Graphical Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Multiple Attack on Bacteria by the New Antibiotic Teixobactin†

Graphical Abstract

References

Citing Literature

References

Related

Information

Multiple Attack on Bacteria by the New Antibiotic Teixobactin^†